Allogene Therapeutics (ALLO) EPS US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EPS, rub | ? | -1.83 | -1.94 | -1.80 | -2.30 | -2.09 | -1.35 | ||
Changes by years, y/y, % | -75% | +6% | -7% | +28% | -9% | -22.2% |
Allogene Therapeutics. EPS, rub
Allogene Therapeutics. EPS, changes, %
Allogene Therapeutics (ALLO) EPS US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EPS, rub | ? | -0.37 | -0.51 | -0.38 | -0.35 | -0.32 | -1.35 | |
Changes by years, y/y, % | -36% | -21% | -44% | -34% | -13% | |||
Changes by quarters, q/q, % | -31% | +39% | -25% | -9% | -9% |